By Fineline Cube 
Germany-based Fresenius Medical Care (FRA: FMEA) released its 2025 Q1 financial report, showing total revenues of EUR 4.88 billion (USD 5.54 billion), with a year-on-year (YOY) increase of 1% in constant exchange rate terms. This growth was driven by the Care Enablement and Care Delivery businesses. Operating income rose 32% YOY to EUR 331 million (USD 375 million).
Business Segment Performance
- Care Delivery: Revenue increased by 2% to EUR 3.857 billion (USD 4.38 billion). On a constant currency basis, revenue decreased by 1% but showed a 4% organic growth. Divestitures as part of the portfolio optimization plan affected revenue development by -370 basis points.
- Care Enablement: Revenue grew by 5% to EUR 1.367 billion (USD 1.55 billion), with a 5% increase both at constant currency and organically. This growth was driven by volume increases across all geographical regions and positive pricing momentum. Volume-based procurement in China developed in line with expectations, supporting volume growth but posing a headwind to price development.
Outlook for 2025
Fresenius Medical Care confirmed its outlook for fiscal year 2025, expecting low single-digit percentage growth in revenue.-Fineline Info & Tech